Makasasa, Sittie Hanah O.

HRN: 28-23-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2025
CEFUROXIME 750MG (VIAL)
12/08/2025
12/15/2025
IV
220mg
Q8hours
PCAP-C
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: